Tranylcypromine

Generic Name
Tranylcypromine
Brand Names
Parnate
Drug Type
Small Molecule
Chemical Formula
C9H11N
CAS Number
155-09-9
Unique Ingredient Identifier
3E3V44J4Z9
Background

A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders (From AMA Drug Evaluations Annual, 1994, p311).
...

Indication

用于抑郁症。

Associated Conditions
Depressive Episodes
Associated Therapies
-
Clinical Trials
Related News

Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy

First Posted Date
2023-11-02
Last Posted Date
2023-11-02
Lead Sponsor
Ankara Etlik City Hospital
Target Recruit Count
75
Registration Number
NCT06114758
Locations
🇹🇷

Etlik City Hospital, Ankara, Turkey

Study of Sensitization of Non-M3 AML Blasts to ATRA by Epigenetic Treatment With Tranylcypromine (TCP)

First Posted Date
2016-03-24
Last Posted Date
2018-10-18
Lead Sponsor
Michael Luebbert
Target Recruit Count
60
Registration Number
NCT02717884
Locations
🇩🇪

Universitätsklinikum Freiburg, Medical School Freiburg, Freiburg, Germany

🇩🇪

Universitätsklinikum Tübingen, Medical School Tuebingen, Tübingen, Tuebingen, Germany

🇩🇪

Universitätsklinikum Heidelberg, Heidelberg, Baden-Wuerttemberg, Germany

and more 3 locations

Pharmacovigilance in Gerontopsychiatric Patients

Phase 3
Terminated
Conditions
Dementia
Depression
Schizophrenia
Psychosomatic Disorders
Anxiety Disorders
Interventions
Drug: Phenobarbital
Drug: Phenytoin
Drug: Carbamazepine
Drug: Oxcarbazepine
Drug: Valproic Acid
Drug: Lamotrigine
Drug: Topiramate
Drug: Gabapentin
Drug: Levetiracetam
Drug: Pregabalin
Drug: Lacosamide
Drug: Clonazepam
Drug: Biperiden
Drug: Levomepromazine
Drug: Fluphenazine
Drug: Perphenazine
Drug: Perazine
Drug: Thioridazine
Drug: Haloperidol
Drug: Melperone
Drug: Pipamperone
Drug: Bromperidol
Drug: Benperidol
Drug: Sertindole
Drug: Ziprasidone
Drug: Flupentixol
Drug: Chlorprothixene
Drug: Zuclopenthixol
Drug: Fluspirilene
Drug: Pimozide
Drug: Clozapine
Drug: Olanzapine
Drug: Quetiapine
Drug: Sulpiride
Drug: Tiapride
Drug: Amisulpride
Drug: Prothipendyl
Drug: Risperidone
Drug: Aripiprazole
Drug: Paliperidone
Drug: Diazepam
Drug: Oxazepam
Drug: Lorazepam
Drug: Bromazepam
Drug: Clobazam
Drug: Alprazolam
Drug: Hydroxyzine
Drug: Buspirone
Drug: Chloral Hydrate
Drug: Flurazepam
Drug: Nitrazepam
Drug: Triazolam
Drug: Lormetazepam
Drug: Temazepam
Drug: Midazolam
Drug: Brotizolam
Drug: Zopiclone
Drug: Zolpidem
Drug: Zaleplon
Drug: Melatonin
Drug: Clomethiazole
Drug: Diphenhydramine
Drug: Promethazine
Drug: Imipramine
Drug: Clomipramine
Drug: Opipramol
Drug: Trimipramine
Drug: Amitriptyline
Drug: Nortriptyline
Drug: Doxepin
Drug: Maprotiline
Drug: Amitriptyline oxide
Drug: Fluoxetine
Drug: Citalopram
Drug: Paroxetine
Drug: Sertraline
Drug: Fluvoxamine
Drug: Escitalopram
Drug: Tranylcypromine
Drug: Moclobemide
Drug: Mianserin
Drug: Trazodone
Drug: Mirtazapine
Drug: Bupropion
Drug: Venlafaxine
Drug: Reboxetine
Drug: Duloxetine
Drug: Agomelatine
Drug: Pyritinol
Drug: Piracetam
Drug: Donepezil
Drug: Rivastigmine
Drug: Galantamine
Drug: Memantine
Drug: Nicergoline
Drug: Acamprosate
Drug: Lithium
First Posted Date
2015-03-02
Last Posted Date
2018-02-28
Lead Sponsor
Hannover Medical School
Target Recruit Count
407
Registration Number
NCT02374567
Locations
🇩🇪

Bezirkskrankenhaus Augsburg, Augsburg, Germany

🇩🇪

Krankenhaus Hedwigshöhe, Berlin, Germany

🇩🇪

Hannover Medical School, Hannover, Germany

and more 2 locations

Study of TCP-ATRA for Adult Patients With AML and MDS

First Posted Date
2014-10-23
Last Posted Date
2020-07-21
Lead Sponsor
University of Miami
Target Recruit Count
17
Registration Number
NCT02273102
Locations
🇺🇸

University of Miami, Miami, Florida, United States

Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible

Phase 1
Conditions
AML
Interventions
Drug: Tranylcypromine
Drug: Tretinoin
First Posted Date
2014-10-10
Last Posted Date
2015-07-07
Lead Sponsor
Martin-Luther-Universität Halle-Wittenberg
Target Recruit Count
16
Registration Number
NCT02261779
Locations
🇩🇪

Universitaetsklinikum Halle, Halle, Germany

Interpersonal Psychotherapy for Treatment Resistant Depression

First Posted Date
2013-07-11
Last Posted Date
2013-07-11
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Target Recruit Count
74
Registration Number
NCT01896349
Locations
🇧🇷

Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil

Tranylcypromine Treatment of Bipolar Depression

Phase 4
Completed
Conditions
Bipolar Disorder I or II
Interventions
Drug: Tranylcypromine
First Posted Date
2011-09-08
Last Posted Date
2018-03-15
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
7
Registration Number
NCT01430455
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

PET Biomarkers in Treatment Resistant Depression

Phase 4
Terminated
Conditions
Major Depressive Disorder
Interventions
Drug: tranylcypromine
First Posted Date
2009-12-15
Last Posted Date
2014-09-18
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
13
Registration Number
NCT01031810
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions

First Posted Date
2008-04-04
Last Posted Date
2008-04-04
Lead Sponsor
Par Pharmaceutical, Inc.
Target Recruit Count
39
Registration Number
NCT00653393
Locations
🇺🇸

SFBC Ft. Myers, Inc, Ft. Myers, Florida, United States

Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression

First Posted Date
2006-02-27
Last Posted Date
2012-04-27
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
31
Registration Number
NCT00296686
Locations
🇺🇸

Depression Evaluation Service - New York State Psychiatric Institute, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy